263 related articles for article (PubMed ID: 23820252)
1. A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients.
Absenger G; Szkandera J; Pichler M; Stotz M; Arminger F; Weissmueller M; Schaberl-Moser R; Samonigg H; Stojakovic T; Gerger A
Br J Cancer; 2013 Jul; 109(2):395-400. PubMed ID: 23820252
[TBL] [Abstract][Full Text] [Related]
2. Preoperative neutrophil-to-lymphocyte ratio predicts clinical outcome in patients with stage II and III colon cancer.
Absenger G; Szkandera J; Stotz M; Postlmayr U; Pichler M; Ress AL; Schaberl-Moser R; Loibner H; Samonigg H; Gerger A
Anticancer Res; 2013 Oct; 33(10):4591-4. PubMed ID: 24123035
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of an inflammatory index for patients with metastatic castration-resistant prostate cancer.
Yamada Y; Sakamoto S; Rii J; Yamamoto S; Kamada S; Imamura Y; Nakamura K; Komiya A; Nakatsu H; Ichikawa T
Prostate; 2020 May; 80(7):559-569. PubMed ID: 32134137
[TBL] [Abstract][Full Text] [Related]
4. The elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patients.
Szkandera J; Pichler M; Absenger G; Stotz M; Arminger F; Weissmueller M; Schaberl-Moser R; Samonigg H; Kornprat P; Stojakovic T; Avian A; Gerger A
Am J Surg; 2014 Aug; 208(2):210-4. PubMed ID: 24581872
[TBL] [Abstract][Full Text] [Related]
5. Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab.
Capone M; Giannarelli D; Mallardo D; Madonna G; Festino L; Grimaldi AM; Vanella V; Simeone E; Paone M; Palmieri G; Cavalcanti E; Caracò C; Ascierto PA
J Immunother Cancer; 2018 Jul; 6(1):74. PubMed ID: 30012216
[TBL] [Abstract][Full Text] [Related]
6. The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer.
Stotz M; Pichler M; Absenger G; Szkandera J; Arminger F; Schaberl-Moser R; Samonigg H; Stojakovic T; Gerger A
Br J Cancer; 2014 Jan; 110(2):435-40. PubMed ID: 24357796
[TBL] [Abstract][Full Text] [Related]
7. Derived neutrophil lymphocyte ratio is predictive of survival from intermittent therapy in advanced colorectal cancer: a post hoc analysis of the MRC COIN study.
Grenader T; Nash S; Adams R; Kaplan R; Fisher D; Maughan T; Bridgewater J
Br J Cancer; 2016 Mar; 114(6):612-5. PubMed ID: 26889974
[TBL] [Abstract][Full Text] [Related]
8. The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients.
Krenn-Pilko S; Langsenlehner U; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
Tumour Biol; 2016 Jan; 37(1):361-8. PubMed ID: 26219894
[TBL] [Abstract][Full Text] [Related]
9. Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.
Dalpiaz O; Pichler M; Mannweiler S; Martín Hernández JM; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC
Br J Cancer; 2014 May; 110(10):2531-6. PubMed ID: 24691424
[TBL] [Abstract][Full Text] [Related]
10. Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma.
Dalpiaz O; Luef T; Seles M; Stotz M; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC; Pichler M
Br J Cancer; 2017 Jan; 116(1):85-90. PubMed ID: 27907929
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy.
Cox S; Hurt C; Grenader T; Mukherjee S; Bridgewater J; Crosby T
Radiother Oncol; 2017 Oct; 125(1):154-159. PubMed ID: 28893415
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients.
Hu H; Yao X; Xie X; Wu X; Zheng C; Xia W; Ma S
World J Urol; 2017 Feb; 35(2):261-270. PubMed ID: 27255479
[TBL] [Abstract][Full Text] [Related]
13. Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab.
Ferrucci PF; Ascierto PA; Pigozzo J; Del Vecchio M; Maio M; Antonini Cappellini GC; Guidoboni M; Queirolo P; Savoia P; Mandalà M; Simeone E; Valpione S; Altomonte M; Spagnolo F; Cocorocchio E; Gandini S; Giannarelli D; Martinoli C
Ann Oncol; 2016 Apr; 27(4):732-8. PubMed ID: 26802161
[TBL] [Abstract][Full Text] [Related]
14. The derived neutrophil/lymphocyte ratio predicts poor clinical outcome in soft tissue sarcoma patients.
Szkandera J; Gerger A; Liegl-Atzwanger B; Stotz M; Samonigg H; Friesenbichler J; Stojakovic T; Leithner A; Pichler M
Am J Surg; 2015 Jul; 210(1):111-6. PubMed ID: 25586599
[TBL] [Abstract][Full Text] [Related]
15. Baseline derived neutrophil-to-lymphocyte ratio as a prognostic biomarker for non-colorectal gastrointestinal cancer patients treated with immune checkpoint blockade.
Li S; Zou J; Liu C; Jiao X; Gong J; Li J; Wang Z; Lu M; Lu Z; Shen L
Clin Immunol; 2020 Mar; 212():108345. PubMed ID: 31953149
[TBL] [Abstract][Full Text] [Related]
16. Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients.
Szkandera J; Absenger G; Liegl-Atzwanger B; Pichler M; Stotz M; Samonigg H; Glehr M; Zacherl M; Stojakovic T; Gerger A; Leithner A
Br J Cancer; 2013 Apr; 108(8):1677-83. PubMed ID: 23558897
[TBL] [Abstract][Full Text] [Related]
17. External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients.
Szkandera J; Stotz M; Eisner F; Absenger G; Stojakovic T; Samonigg H; Kornprat P; Schaberl-Moser R; Alzoughbi W; Ress AL; Seggewies FS; Gerger A; Hoefler G; Pichler M
PLoS One; 2013; 8(11):e78225. PubMed ID: 24223776
[TBL] [Abstract][Full Text] [Related]
18. Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?
Dirican A; Kucukzeybek BB; Alacacioglu A; Kucukzeybek Y; Erten C; Varol U; Somali I; Demir L; Bayoglu IV; Yildiz Y; Akyol M; Koyuncu B; Coban E; Ulger E; Unay FC; Tarhan MO
Int J Clin Oncol; 2015 Feb; 20(1):70-81. PubMed ID: 24532163
[TBL] [Abstract][Full Text] [Related]
19. Circulating CEA-dNLR score predicts clinical outcome of metastatic gallbladder cancer patient.
Du JH; Lu J
J Clin Lab Anal; 2019 Feb; 33(2):e22684. PubMed ID: 30461064
[TBL] [Abstract][Full Text] [Related]
20. The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma.
Troppan K; Deutsch A; Gerger A; Stojakovic T; Beham-Schmid C; Wenzl K; Neumeister P; Pichler M
Br J Cancer; 2014 Jan; 110(2):369-74. PubMed ID: 24357794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
